ANI Pharma rises as rare-disease drugs drive quarterly results beat

ANI Pharmaceuticals

28/02/2025 14:01

** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise 11.8% to $61 premarket

** Co reports Q4 revenue of $190.6 mln, beating analysts' average estimate of $175.4 mln, on strong demand for rare-disease drugs Iluvien and Yutiq - data compiled by LSEG

** Posts adj. Q4 profit of $1.63 per share vs estimates of $1.44

** Stock has fallen 8.9% in past 12 months

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com;))